Inoperable Stage III Non-small Cell Lung Cancer
1 clinical trials · Condition
◉ Watch Inoperable Stage III Non-small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| Study of the Telomerase Vaccine GV1001 to Treat Patients With Inoperable Stage III Non-small Cell Lung Cancer (NCT01579188) | Kael-GemVax Co., Ltd. | 2012-05-01 |
Track Inoperable Stage III Non-small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.